Therapeutic Proteins Inc (TPI) is a world-class manufacturer
of biological drugs, both innovative and generic, using its breakthrough technology that allows GMP manufacturing of
the highest quality of these drugs at the lowest possible cost at large commercial scale with minimal capital cost. The scientific innovations of TPI include in-situ pegylation for proteins and backbone strengthening of monoclonal antibodies to create the second-generation molecules with longer acting profiles and
higher storage stability.